Cargando…
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping
Next-generation sequencing (NGS) is increasingly used for HIV-1 drug resistance genotyping. NGS methods have the potential for a more sensitive detection of low-abundance variants (LAV) compared to standard Sanger sequencing (SS) methods. A standardized threshold for reporting LAV that generates dat...
Autores principales: | Parkin, Neil T., Avila-Rios, Santiago, Bibby, David F., Brumme, Chanson J., Eshleman, Susan H., Harrigan, P. Richard, Howison, Mark, Hunt, Gillian, Ji, Hezhao, Kantor, Rami, Ledwaba, Johanna, Lee, Emma R., Matías-Florentino, Margarita, Mbisa, Jean L., Noguera-Julian, Marc, Paredes, Roger, Rivera-Amill, Vanessa, Swanstrom, Ronald, Zaccaro, Daniel J., Zhang, Yinfeng, Zhou, Shuntai, Jennings, Cheryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411816/ https://www.ncbi.nlm.nih.gov/pubmed/32605062 http://dx.doi.org/10.3390/v12070694 |
Ejemplares similares
-
Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium
por: Ji, Hezhao, et al.
Publicado: (2020) -
Bioinformatic data processing pipelines in support of next‐generation sequencing‐based HIV drug resistance testing: the Winnipeg Consensus
por: Ji, Hezhao, et al.
Publicado: (2018) -
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing
por: Jennings, Cheryl, et al.
Publicado: (2020) -
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing
por: Lee, Emma R., et al.
Publicado: (2020) -
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
por: Ávila-Ríos, Santiago, et al.
Publicado: (2020)